3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Leukemia, Myeloid, Acute
3
Carcinoma, Non-Small-Cell Lung
2
Recurrence
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Myeloid Malignancies
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Epstein-Barr Virus Infections
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Interventions
fludarabine phosphate
7
Peripheral Blood Stem Cell Transplantation
7
Whole-Body Irradiation
6
Mycophenolic Acid
6
Cyclosporine
5
Cyclophosphamide
5
Rituximab
4
Tacrolimus
3
Melphalan
3
Busulfan
3
Antilymphocyte Serum
3
Alemtuzumab
3
thymoglobulin
2
fludarabine
2
Thiotepa
2
Radiotherapy
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Darbepoetin alfa
2
Cyclosporins
2
plerixafor
1
merphos
1
ferrous sulfate
1
ferric gluconate
1
blinatumomab
1
Transplantation
1
Therapeutics
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Large Granular Lymphocytic
×
cc-486
×
Clear all
No trials found.